Betamethasone dipropionate was administered intramuscularly to fifty-one patients with chronic bronchial asthma. Good to excellent results were obtained in 96% of patients. Onset of action was rapid, and duration of action was prolonged. Adverse reactions were mild and transient. Decreases in early morning plasma cortisol levels were also transient with the levels returning to normal range by the end of the study in all but one patient.
Get full access to this article
View all access options for this article.
References
1.
AbramL EFineA J (1967) Use of betamethasone in intractable asthma. Western Medicine2, 61.
2.
AsrilantM (1967) A study of the therapeutic activity of a parenterally administered corticosteroid combination in bronchial asthma. El Dia Medico39 (28), 470.
3.
BeumerH M (1968) De Behandeling Van Asthma Bronchials en Longemfyseem Met Betamethasone. Oorspronkelijke Stukken Jan/Feb, 19.
4.
CarryerH M (1950) Effects of cortisone on bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollen. Proceedings of the Mayo Clinic25, 482.
5.
GraterW CBrownE B (1969) Injectable steroids in allergy;Annals of Allergy27, 321.
6.
HamptonS F (1961) Betamethasone – a new steroid in allergy: A preliminary report: Presented 1st Conf. Clin. Appl. Betamethasone – A New Corticosteroid. New York, May 8, 1961.
7.
IlligH (1967) Betamethason bei Asthmatischem Syndrom;Medizinische Klinik62, 912.
8.
JacynaK (1977) Clinical evaluation of a new betamethasone preparation (‘Diprospan’) in the treatment of bronchial asthma. Pharmatherapeutica1, 673.
9.
LawrenceD R (1963) Clinical Pharmacology. J & A Churchill Ltd, London. p 286.
10.
LjaljevicM (1976) Comparison of a prolonged acting betamethasone phosphate dipropionate preparation (Diprospan) with methylprednisolone acetate. Clinical Trials Journal13, 124.
